Stay updated on Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial
Sign up to get notified when there's something new on the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page.

Latest updates to the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded clarifying note that publications are automatically populated from PubMed and may not be related to the study, and updated the revision version from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe general funding/operating status notice has been removed from the page. It previously warned that information may not be up to date and that NIH Clinical Center operations could be affected.SummaryDifference0.4%

- Check43 days agoChange DetectedNo significant changes detected on the Study Details page; the core study information such as title, conditions, enrollment, and primary outcomes appears unchanged between the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference4%

- Check79 days agoChange DetectedUpgrade noted: version from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No changes to pricing, stock, or other core content.SummaryDifference0.2%

Stay in the know with updates to Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page.